The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
 
Springer Nature

2019

 

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

SOCS3 and IRS-1 Gene Expression Differs Between Genotype 1 and Genotype 2 HCV-Infected HEPG2 Cells

Persico M, Russo R, Persico E, Svelto M, Spano D, Andolfo I, La Mura V, Capasso M, Tiribelli C, Torella R, Iolascon A.

Clin Chem Mol Med., Oct; 47(10):1217-25

2009

Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology

Chavez-Tapia1 NC, Tellez-Avila FC, Bedogni G, Crocè LS, Masutti F and Tiribelli C.

BMC Gastroenterology , Oct, 9:75. (rev)

2009

A protective effect of breastfeeding on the progression of nonalcoholic fatty liver disease

Nobili V, Bedogni G, Alisi A, Pietrobattista A, Alterio A, Tiribelli C, Agostoni C.

Archives of Disease in Childhood, Oct, 94(10):801-5

2009

Bilirubin effect on endothelial adhesion molecules expression is mediated by the NF-kB signaling pathway

Mazzone GL, Rigato I, Ostrow JD. Tiribelli C.

BioScience Trends. Aug, 3:151-157.

2009

Bilirubin inhibits the TNFa related induction of three endothelial adhesion molecules

Mazzone GL, Ostrow JD, Bossi F, Bortoluzzi A; Sukowati CH, Tedesco F, Tiribelli C.

Biochem Biophys Res Comm, Aug, 386:338-344.

2009

Cross-validation of bioelectrical impedance analysis for the assessment of body composition in a representative sample of 6-13 year-old children

Kriemler S, Puder J, Zahner L, Roth R, Braun-Fahrländer C, Bedogni G.

European Journal of Clinical Nutrition, May;63:619-626

2009

Differential proteomic analysis of subfractioned human hepatocellular carcinoma tissues

Codarin E, Renzone G, Poz A, Avellini C, Baccarani U, Lupo F, Di Maso V, Crocè LS, Tiribelli C, Arena S, Quadrifoglio F; Scaloni A; Tell G.

Journal of Proteome Research, May, 8:2373-2384.

2009

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G.

BMC Medicine, May,7:21 (doi:10.1186/1741-7015-7-21).

2009

Subzero nonfreezing storage of rat hepatocytes using UW solution and 1,4-butanediol. II- functional testing on rewarming and gene expression of urea cycle enzymes

Guibert EE, Almada LL; Mamprin ME; Bellarosa C; Pizarro MD; Tiribelli C, Rodriguez JV.

Annals of Hepatology, Apr-Jun; 8: 129-133

2009

Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations

Scaloni A, Codarin E, Di Maso V, Arena S, Renzone G, Tiribelli C, Quadrifoglio F, Tell G.

Proteomics (Clinical Applications) Feb, 3:242-262. (rev)

2009

Transcutaneous bilirubin measurements: useful, but also reproducible?

Dani C, Hulzebos CV, Tiribelli C

Pediatr Res. 2020. doi: 10.1038/s41390-020-01242-3.

2020

Elastography: where are we now?

Giuffré M, Colecchia A, Crocé LS

Minerva Gastroenterol Dietol. 2020. doi: 10.23736/S1121-421X.20.02773-7.

2020

The role of bilirubin and other “yellow players” in neurodegenerative diseases

Jayanti S, Vitek L, Tiribelli C, Gazzin S

Antioxidants. 9(9):900. doi: 10.3390/antiox9090900.

2020

Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation

Vítek L, Tiribelli C

N Engl J Med 2020 Aug 13;383(7):684-686.doi: 10.1056/NEJMcibr2013250.

2020

HCC occurrence after DAA treatments: Molecular tools to assess the post-treatment risk and surveillance

Pascut D, Pratama MY, Tiribelli C

Hepat Oncol. 2020 Jun 22;7(2):HEP21. doi: 10.2217/hep-2020-0010

2020

Sorafenib resistance in hepatocellular carcinoma: The relevance of genetic heterogeneity

Cabral KL, Tiribelli C, Sukowati CHC

Cancers (Basel). 2020 Jun 15;12(6):E1576. doi: 10.3390/cancers12061576.

2020

Charles E. Ahlfors (1944–2020)

Wennberg RP, Wong RJ, Shapiro SM, Tiribelli C

Pediatr Res. 2020 May 6. doi: 10.1038/s41390-020-0938-y.

2020

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

Eslam M, Sanyal AJ, George J, on behalf of an international consensus panel (including Tiribelli C)    

Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312.

2020

A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature

Giuffrè M, Campigotto M, Campisciano G, Comar M, Crocè LS

Am J Physiol Gastrointest Liver Physiol.318(5):G889-G906 doi: 101152/ajpgi001612019

2020

Sex differences in Non-Alcoholic Fatty Liver Disease: Hints for future management of the disease

Salvoza NC, Giraudi PJ, Tiribelli C, Rosso N

Explor Med. 2020;1:51-74 DOI: https://doi.org/10.37349/emed.2020.00005

2020